Molecular subtypes in cancers of the gastrointestinal tract

被引:95
|
作者
Bijlsma, Maarten F. [1 ]
Sadanandam, Anguraj [2 ]
Tan, Patrick [3 ]
Vermeulen, Louis [1 ]
机构
[1] Univ Amsterdam, Acad Med Ctr, Ctr Expt & Mol Med, Lab Expt Oncol & Radiobiol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands
[2] Inst Canc Res, Div Mol Pathol, 15 Cotswold Rd, London SM2 5NG, England
[3] Duke NUS Med Sch, Canc & Stem Cell Biol Program, 8 Coll Rd, Singapore 169857, Singapore
基金
欧洲研究理事会; 英国医学研究理事会;
关键词
PANCREATIC DUCTAL ADENOCARCINOMA; COLORECTAL-CANCER; GASTRIC-CANCER; GENETIC LANDSCAPE; NEUROENDOCRINE TUMORS; GENOMIC ALTERATIONS; MUTATIONS; SURVIVAL; IDENTIFICATION; EXPRESSION;
D O I
10.1038/nrgastro.2017.33
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Malignancies of the gastrointestinal tract are among the most common human cancers. The distinct tissues of origin give rise to a diverse set of diseases, such as colorectal cancer, pancreatic carcinoma and gastric cancers, with each associating with specific clinical features. Genomic and transcriptomic analyses have further defined the heterogeneity that occurs within these cancers by identifying so-called molecular subtypes. These subtypes are characterized by specific genetic aberrations and expression signatures that suggest important biological differences. Although at first sight this subdivision of organ-specific cancers might increase the complexity of classification, closer analysis suggests that the subtypes detected in the various malignancies are recurring. For example, nearly all gastrointestinal cancers appear to present with subtypes that are either characterized by a mesenchymal gene expression signatures, extensive immune infiltration or metabolic dysregulation. Additionally, in each of the gastrointestinal malignancies, a 'canonical' subtype is recognized that retains characteristic features of the epithelial tissue of origin. These common themes can enhance our collective understanding of these malignancies, and could perhaps be therapeutically exploited. In this Review, the identification of subtypes in the various gastrointestinal cancer types are discussed along with how they could be incorporated into clinical practice.
引用
收藏
页码:333 / 342
页数:10
相关论文
共 50 条
  • [21] The role of microRNAs in cancers of the upper gastrointestinal tract
    Shumei Song
    Jaffer A. Ajani
    Nature Reviews Gastroenterology & Hepatology, 2013, 10 : 109 - 118
  • [22] DNA repair dysfunction in gastrointestinal tract cancers
    Maehara, Yoshihiko
    Egashira, Akinori
    Oki, Eiji
    Kakeji, Yoshihiro
    Tsuzuki, Teruhisa
    CANCER SCIENCE, 2008, 99 (03) : 451 - 458
  • [23] Adjuvant therapy of upper gastrointestinal tract cancers
    Kelsen, DP
    SEMINARS IN ONCOLOGY, 1995, 22 (06) : 582 - 599
  • [24] PET/MR Imaging in Cancers of the Gastrointestinal Tract
    Paspulati, Raj Mohan
    Gupta, Amit
    PET CLINICS, 2016, 11 (04) : 403 - +
  • [25] Recent developments in immunotherapy for gastrointestinal tract cancers
    Chong, Xiaoyi
    Madeti, Yelizhati
    Cai, Jieyuan
    Li, Wenfei
    Cong, Lin
    Lu, Jialin
    Mo, Liyang
    Liu, Huizhen
    He, Siyi
    Yu, Chao
    Zhou, Zhiruo
    Wang, Boya
    Cao, Yanshuo
    Wang, Zhenghang
    Shen, Lin
    Wang, Yakun
    Zhang, Xiaotian
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2024, 17 (01)
  • [26] Cruciferous Vegetables and Risk of Cancers of the Gastrointestinal Tract
    Johnson, Ian T.
    MOLECULAR NUTRITION & FOOD RESEARCH, 2018, 62 (18)
  • [27] Gastrointestinal tract cancers - global burden and trends
    Hakulinen, Timo
    ACTA ONCOLOGICA, 2007, 46 (03) : 400 - 401
  • [28] The Role of Gut Microbiota in Gastrointestinal Tract Cancers
    Grochowska, Marta
    Perlejewski, Karol
    Laskus, Tomasz
    Radkowski, Marek
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2022, 70 (01)
  • [29] Targeting cancers in the gastrointestinal tract: role of capecitabine
    Saif, Muhammad Wasif
    ONCOTARGETS AND THERAPY, 2009, 2 : 29 - 41
  • [30] The Role of Gut Microbiota in Gastrointestinal Tract Cancers
    Marta Grochowska
    Karol Perlejewski
    Tomasz Laskus
    Marek Radkowski
    Archivum Immunologiae et Therapiae Experimentalis, 2022, 70